What is ADHD? | Tris Pharma

About ADHD

Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental condition that affects children and adults worldwide. It is usually first diagnosed in childhood and often lasts into adulthood. It is characterized by a persistent pattern of inattention and/or hyperactivity-impulsivity that can interfere with daily activities and relationships.1,2

People with ADHD experience an ongoing pattern of the following types of symptoms:1

  • Inattention—having difficulty paying attention
  • Hyperactivity—having too much energy or moving and talking too much
  • Impulsivity—acting without thinking or having difficulty with self-control

Some people with ADHD mainly have symptoms of inattention. Others mostly have symptoms of hyperactivity-impulsivity. Some people have both types of symptoms.1

There is no single test to diagnose ADHD, and many other problems, like anxiety, depression, sleep problems, and certain types of learning disabilities, can have similar symptoms. Because of this, a thorough evaluation by a healthcare professional is necessary to determine the cause of the symptoms.1

Currently available treatments may reduce symptoms and improve functioning in ADHD patients. Treatments include medication, psychosocial interventions, education or training, or a combination of treatments.1

There are many treatment options, and what works best can depend on the individual. It is recommended that patients work with healthcare providers to find the best treatment plan.1

Recent studies link genetic factors with ADHD. Scientists are studying cause(s) and risk factors in an effort to find better ways to manage ADHD. Many cause(s) and risk factors for ADHD are unknown, but current research shows that genetics plays an important role. In addition to genetics, scientists are studying other possible causes and risk factors.1

ADHD treatment

In many cases, ADHD is treated with a combination of psychosocial interventions and medication. Treatment plans will include regular monitoring, follow-ups, and making changes, if needed, along the way. It is important to talk to your doctor and communicate any questions or concerns you may have.1

FDA-approved medications for the treatment of ADHD include stimulants and non-stimulants. Stimulant ADHD treatments fall into the category of methylphenidate or amphetamine. A healthcare prescriber’s decision to prescribe an ADHD medication ultimately depends on a few key factors:

  • The patient’s individual needs
  • Prior experience with methylphenidate, amphetamines, or non-stimulants
  • Health conditions the patient may have or other medications the patient may be taking

Methylphenidate and amphetamine are both stimulant medications that are often used in the treatment of ADHD. Although both types of stimulants have similar efficacy, some patients may respond to or tolerate one or the other better.2

It is important to work with your healthcare provider to find the medication that works best for you or for your child.

Besides stimulants, like methylphenidates and amphetamines, non-stimulants are also used to treat ADHD. Non-stimulants may be prescribed to a patient when stimulant medications have either not been effective or have been shown to cause unwanted side effects for the patient. Doctors may consider using non-stimulants in patients with certain conditions.2

Treatments for ADHD may include medication, psychosocial interventions, or a combination of methods. ADHD education, skills training and parent training, and school accommodations can all play an important role in an ADHD treatment plan. Doctors and patients can work together to find the best treatment plan and determine whether medication is necessary to manage ADHD symptoms.1

Tris ADHD Resources

Did you know that you may be able to save on your or your child’s ADHD medication?*

Choose a savings offer based on the product that your doctor has prescribed.

*Co-pay offer is subject to eligibility. Terms and Conditions apply.

References: 1. US Department of Health and Human Services. National Institutes of Health. Attention Deficit/Hyperactivity Disorder in Children and Teens: What you need to know. NIH Publication No. 21-MH-8159. 2021. 2. Faraone SV, Bellgrove MA, Brikell I, et al. Attention-deficit/hyperactivity disorder. Nature reviews disease primers. (2024); 10:11: https://doi.org/10.1038/s41572-024-00495-0

Important Safety Information & Approved Use

DYANAVEL® XR (amphetamine) is a federally controlled substance (CII) because it contains amphetamine that can be a target for people who abuse prescription medicines or street drugs. DYANAVEL XR has a high chance for abuse and misuse and may lead to substance use problems, including addiction. Keep DYANAVEL XR in a safe place to prevent abuse and misuse. Never give your DYANAVEL XR to anyone else because it may cause death or harm them. Selling or giving away DYANAVEL XR may harm others and is against the law.

See Additional Important Safety Information.

To report SUSPECTED ADVERSE REACTIONS, contact Tris Pharma, Inc. at (732) 940-0358 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch

Important Safety Information & Approved Use

DYANAVEL® XR (amphetamine) is a federally controlled substance (CII) because it contains amphetamine that can be a target for people who abuse prescription medicines or street drugs. DYANAVEL XR has a high chance for abuse and misuse and may lead to substance use problems, including addiction. Keep DYANAVEL XR in a safe place to prevent abuse and misuse. Never give your DYANAVEL XR to anyone else because it may cause death or harm them. Selling or giving away DYANAVEL XR may harm others and is against the law.

Your healthcare provider should check you or your child's risk for abuse, misuse, and addiction before starting treatment with DYANAVEL XR and will monitor you or your child during treatment.

Tell your physician if you, your child, or any family members have ever abused or been dependent on alcohol prescription medicines, or street drugs.

DYANAVEL XR should not be taken if you or your child are allergic to amphetamine or any of the ingredients in DYANAVEL XR or are taking or have taken within the past 14 days an anti-depression medicine called a monoamine oxidase inhibitor or MAOI including the antibiotic linezolid and the intravenous medicine methylene blue.

DYANAVEL XR can cause serious side effects including:

  • Risks for people with serious heart disease: Sudden death has happened in people who have heart defects or other serious heart disease. Before starting DYANAVEL XR, tell your healthcare provider if you or your child have any heart problems, heart disease, or heart defects.
    Call your healthcare provider or go to the nearest hospital emergency room right away if you or your child has any signs of heart problems such as chest pain, shortness of breath, or fainting during treatment with DYANAVEL XR.
  • Increase in blood pressure and heart rate.
    Your healthcare provider should check your or your child’s blood pressure and heart rate regularly during treatment with DYANAVEL XR.
  • Mental (psychiatric) problems, including new or worse behavior and thought problems, new or worse bipolar illness, new psychotic symptoms (such as hearing voices, or seeing or believing things that are not real) or new manic symptoms.
    Tell your healthcare provider about any mental problems you or your child have, or about a family history of suicide, bipolar illness, or depression. Call the doctor right away if there are any new or worsening mental symptoms during treatment.
  • Circulation problems in fingers and toes (peripheral vasculopathy, including Raynaud’s phenomenon). Tell your healthcare provider if you or your child have numbness, pain, skin color change, or sensitivity to temperature in your fingers or toes.
    Call the doctor right away if you or your child have any signs of unexplained wounds appearing on fingers or toes during treatment with DYANAVEL XR.
  • New or worsening tics or worsening Tourette’s syndrome. Tell your healthcare provider if you or your child get any new or worsening tics or worsening Tourette’s syndrome during treatment with DYANAVEL XR.
  • Serotonin Syndrome. This problem may happen when DYANAVEL XR is taken with certain other medicines and may be life-threatening. Stop taking DYANAVEL XR and call your healthcare provider or go to the nearest hospital emergency room if you get symptoms such as agitation, hallucinations, coma, or other changes in mental status; fast heartbeat; sweating or fever; nausea, vomiting, diarrhea; high or low blood pressure; problems controlling movements or muscle twitching; muscle stiffness or tightness.
  • Slowing of growth (height and weight) in children. Children should have their height and weight checked often during treatment with DYANAVEL XR. Your healthcare provider may stop your child’s DYANAVEL XR treatment if they are not growing or gaining weight as expected.
  • It is not known if DYANAVEL XR will harm the unborn baby. There is a pregnancy registry for females who are exposed to DYANAVEL XR during pregnancy. The purpose of the registry is to collect information about the health of females exposed to DYANAVEL XR and their baby. If you or your child becomes pregnant during treatment with DYANAVEL XR, talk to your healthcare provider about registering with the National Pregnancy Registry for Psychostimulants at 1-866-961-2388 or visit https://womensmentalhealth.org/clinical-and-research-programs/pregnancyregistry/othermedications/.
  • DYANAVEL XR passes into breast milk. You or your child should not breastfeed during treatment with DYANAVEL XR. Tell your doctor if you are breastfeeding or plan to breastfeed.
  • The most common side effects of amphetamine products include:

    – dry mouth

    – decreased appetite

    – weight loss

    – stomach pain

    – nausea

    – trouble sleeping

    – restlessness

    – extreme mood changes

    – dizziness

    – increased heart rate

Talk to your doctor if you or your child have any side effects that bother you or do not go away.
Avoid drinking alcohol while taking DYANAVEL XR.

To report SUSPECTED ADVERSE REACTIONS, contact Tris Pharma, Inc. at (732) 940-0358 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch

APPROVED USE

DYANAVEL XR is a central nervous system (CNS) stimulant prescription medicine used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in people 6 years and older. DYANAVEL XR may help increase attention and decrease impulsiveness and hyperactivity in people with ADHD.

It is not known if DYANAVEL XR is safe and effective in children under 6 years of age.

Please see Full Prescribing Information, including Boxed Warning about Abuse, Misuse and Addiction and Medication Guide.

How can we help?

Sign up to get answers or request more information on DYANAVEL® XR (amphetamine)

Request Info
up arrowTop